Signaling pathways activated by oncogenic forms of Abl tyrosine kinase (Q33663180)

28 July 2017

1 reference

title

Signaling pathways activated by oncogenic forms of Abl tyrosine kinase (English)

1 reference

28 July 2017

Zou X

1

1 reference

PubMed ID

10373409

28 July 2017

Calame K

series ordinal

2

1 reference

PubMed ID

10373409

28 July 2017

language of work or name

English

0 references

publication date

1 June 1999

1 reference

Journal of Biological Chemistry

28 July 2017

4

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

28 July 2017

274

1 reference

28 July 2017

26

1 reference

28 July 2017

18141-18144

1 reference

Chronic myelogenous leukemia: a review

28 July 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Antagonistic effects of ABL and BCRABL proteins on proliferation and the response to genotoxic stress in normal and leukemic myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: Studies with cloned viral DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Abl tyrosine protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Negative regulation of p120GAP GTPase promoting activity by p210bcr/abl: implication for RAS-dependent Philadelphia chromosome positive cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Requirement for c-ras proteins during viral oncogene transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Increasing complexity of Ras signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

In vivo association of v-Abl with Shc mediated by a non-phosphotyrosine-dependent SH2 interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

The CRKL adaptor protein transforms fibroblasts and functions in transformation by the BCR-ABL oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Role of the adapter protein CRKL in signal transduction of normal hematopoietic and BCR/ABL-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-abl transforming activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Isolation and characterization of e3B1, an eps8 binding protein that regulates cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Constitutive phosphorylation of eps8 in tumor cell lines: relevance to malignant transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Inhibition of the Raf-1 kinase by cyclic AMP agonists causes apoptosis of v-abl-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Dominant negative MYC blocks transformation by ABL oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Raf1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

p14ARF links the tumour suppressors RB and p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Blastic transformation of p53-deficient bone marrow cells by p210bcr/abl tyrosine kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

p19(Arf) induces p53-dependent apoptosis during abelson virus-mediated pre-B cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Rac is required for v-Abl tyrosine kinase to activate mitogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

BCR/ABL-mediated leukemogenesis requires the activity of the small GTP-binding protein Rac.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Regulation of Bcr-Abl-induced SAP kinase activity and transformation by the SHPTP1 protein tyrosine phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Activation of phosphatidylinositol 3-kinase in cells expressing abl oncogene variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Direct interaction of Jak1 and v-Abl is required for v-Abl-induced activation of STATs and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

v-Abl protein tyrosine kinase (PTK) mediated suppression of apoptosis is associated with the up-regulation of Bcl-XL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Jak-STAT signaling induced by the v-abl oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Transcriptional responses to polypeptide ligands: the JAK-STAT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Cytokine rescue of p53-dependent apoptosis and cell cycle arrest is mediated by distinct Jak kinase signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

The v-abl tyrosine kinase negatively regulates NF-kappa B/Rel factors and blocks kappa gene transcription in pre-B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

Regulation of Bcl-2 gene expression by BCR-ABL is mediated by Ras.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.274.26.18141

21 January 2018

Identifiers

DOI

10.1074/JBC.274.26.18141

1 reference

28 July 2017

1 reference

PubMed ID

10373409